|
1
|
Lange F, Hörnschemeyer J and Kirschstein
T: Glutamatergic mechanisms in glioblastoma and tumor-associated
epilepsy. Cells. 10(1226)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhao K, Gu J and Zhao B: The effect of
epilepsy on anxiety, depression, as well as prognostic value among
adult low-grade gliomas patients. Brain Res.
1863(149737)2025.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liang S, Fan X, Zhao M, Shan X, Li W, Ding
P, You G, Hong Z, Yang X, Luan G, et al: Clinical practice
guidelines for the diagnosis and treatment of adult diffuse
glioma-related epilepsy. Cancer Med. 8:4527–4535. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pallud J and McKhann GM: Diffuse low-grade
glioma-related epilepsy. Neurosurg Clin N Am. 30:43–54.
2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Du Y, Li R, Fu D, Zhang B, Cui A, Shao Y,
Lai Z, Chen R, Chen B, Wang Z, et al: Multi-omics technologies and
molecular biomarkers in brain tumor-related epilepsy. CNS Neurosci
Ther. 30(e14717)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Radin DP and Tsirka SE: Interactions
between tumor cells, neurons, and microglia in the glioma
microenvironment. Int J Mol Sci. 21(8476)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pallud J, Roux A, Moiraghi A, Aboubakr O,
Elia A, Guinard E, Oppenheim C, Tauziede-Espariat A, Parraga E,
Gavaret M, et al: Characteristics and prognosis of tumor-related
epilepsy during tumor evolution in patients with IDH wild-type
glioblastoma. Neurology. 102(e207902)2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Goldstein ED and Feyissa AM: Brain tumor
related-epilepsy. Neurol Neurochir Pol. 52:436–447. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
van der Meer PB, Taphoorn MJB and Koekkoek
JAF: Management of epilepsy in brain tumor patients. Curr Opin
Oncol. 34:685–690. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zoccarato M, Nardetto L, Basile AM,
Giometto B, Zagonel V and Lombardi G: Seizures, edema, thrombosis,
and hemorrhages: An update review on the medical management of
gliomas. Front Oncol. 11(617966)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
van Breemen MS, Wilms EB and Vecht CJ:
Epilepsy in patients with brain tumours: Epidemiology, mechanisms,
and management. Lancet Neurol. 6:421–430. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kerkhof M and Vecht CJ: Seizure
characteristics and prognostic factors of gliomas. Epilepsia. 54
(Suppl 9):S12–S17. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
van Breemen MS, Rijsman RM, Taphoorn MJ,
Walchenbach R, Zwinkels H and Vecht CJ: Efficacy of anti-epileptic
drugs in patients with gliomas and seizures. J Neurol.
256:1519–1526. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang Y, Mao Q, Wang X, Liu Y, Mao Y, Zhou
Q and Luo J: An analysis of 170 glioma patients and systematic
review to investigate the association between IDH-1 mutations and
preoperative glioma-related epilepsy. J Clin Neurosci. 31:56–62.
2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Knudsen-Baas KM, Power KN, Engelsen BA,
Hegrestad SE, Gilhus NE and Storstein AM: Status epilepticus
secondary to glioma. Seizure. 40:76–80. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fernández-Torre JL, Hernández-Hernández M,
Martino J and Hinojo C: Subclinical focal seizures as a sign of
progression in gliomas. Epileptic Disord. 16:546–553.
2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mastall M, Wolpert F, Gramatzki D, Imbach
L, Becker D, Schmick A, Hertler C, Roth P, Weller M and Wirsching
HG: Survival of brain tumour patients with epilepsy. Brain.
144:3322–3327. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Debinski W: Gliomas. Exon Publications,
Brisbane, 2021.
|
|
19
|
Cavaliere R, Farace E and Schiff D:
Clinical implications of status epilepticus in patients with
neoplasms. Arch Neurol. 63:1746–1749. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Fisher RS, van Emde Boas W, Blume W, Elger
C, Genton P, Lee P and Engel J Jr: Epileptic seizures and epilepsy:
Definitions proposed by the International league against epilepsy
(ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia.
46:470–472. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kurokawa R, Baba A, Emile P, Kurokawa M,
Ota Y, Kim J, Capizzano A, Srinivasan A and Moritani T:
Neuroimaging features of angiocentric glioma: A case series and
systematic review. J Neuroimaging. 32:389–399. 2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li Y, Shan X, Wu Z, Wang Y, Ling M and Fan
X: IDH1 mutation is associated with a higher preoperative seizure
incidence in low-grade glioma: A systematic review and
meta-analysis. Seizure. 55:76–82. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhong Z, Wang Z, Wang Y, You G and Jiang
T: IDH1/2 mutation is associated with seizure as an initial symptom
in low-grade glioma: A report of 311 Chinese adult glioma patients.
Epilepsy Res. 109:100–105. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Nobusawa S, Watanabe T, Kleihues P and
Ohgaki H: IDH1 mutations as molecular signature and predictive
factor of secondary glioblastomas. Clin Cancer Res. 15:6002–6007.
2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bhandari AP, Liong R, Koppen J, Murthy SV
and Lasocki A: Noninvasive determination of IDH and 1p19q status of
lower-grade gliomas using MRI Radiomics: A systematic review. AJNR
Am J Neuroradiol. 42:94–101. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gao A, Yang H, Wang Y, Zhao G, Wang C,
Wang H, Zhang X, Zhang Y, Cheng J, Yang G and Bai J: Radiomics for
the prediction of epilepsy in patients with frontal glioma. Front
Oncol. 11(725926)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jie B, Hongxi Y, Ankang G, Yida W, Guohua
Z, Xiaoyue M, Chenglong W, Haijie W, Xiaonan Z, Guang Y, et al:
Radiomics nomogram improves the prediction of epilepsy in patients
with gliomas. Front Oncol. 12(856359)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang Y, Gao A, Yang H, Bai J, Zhao G,
Zhang H, Song Y, Wang C, Zhang Y, Cheng J and Yang G: Using
partially shared radiomics features to simultaneously identify
isocitrate dehydrogenase mutation status and epilepsy in glioma
patients from MRI images. Sci Rep. 15(3591)2025.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Armstrong TS, Grant R, Gilbert MR, Lee JW
and Norden AD: Epilepsy in glioma patients: mechanisms, management,
and impact of anticonvulsant therapy. Neuro Oncol. 18:779–789.
2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hauff NS and Storstein A: Seizure
management and prophylaxis considerations in patients with brain
tumors. Curr Oncol Rep. 25:787–792. 2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sirven JI, Wingerchuk DM, Drazkowski JF,
Lyons MK and Zimmerman RS: Seizure prophylaxis in patients with
brain tumors: A meta-analysis. Mayo Clin Proc. 79:1489–1494.
2004.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Englot DJ, Chang EF and Vecht CJ: Epilepsy
and brain tumors. Handb Clin Neurol. 134:267–285. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen DY, Chen CC, Crawford JR and Wang SG:
Tumor-related epilepsy: Epidemiology, pathogenesis and management.
J Neurooncol. 139:13–21. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Westermark A, Fahlström M, Mirza S,
Zetterling M, Kumlien E and Latini F: Subcortical brain regions
associated with seizure risk in patients with IDH mutated diffuse
gliomas. Brain Behav. 15(e70477)2025.PubMed/NCBI View Article : Google Scholar
|
|
35
|
John Lin CC, Yu K, Hatcher A, Huang TW,
Lee HK, Carlson J, Weston MC, Chen F, Zhang Y, Zhu W, et al:
Identification of diverse astrocyte populations and their malignant
analogs. Nat Neurosci. 20:396–405. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yang P, Liang T, Zhang C, Cai J, Zhang W,
Chen B, Qiu X, Yao K, Li G, Wang H, et al: Clinicopathological
factors predictive of postoperative seizures in patients with
gliomas. Seizure. 35:93–99. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hills KE, Kostarelos K and Wykes RC:
Converging mechanisms of epileptogenesis and their insight in
glioblastoma. Front Mol Neurosci. 15(903115)2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Seidel S, Wehner T, Miller D, Wellmer J,
Schlegel U and Grönheit W: Brain tumor related epilepsy:
Pathophysiological approaches and rational management of
antiseizure medication. Neurol Res Pract. 4(45)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bartos LM, Quach S, Zenatti V,
Kirchleitner SV, Blobner J, Wind-Mark K, Kolabas ZI, Ulukaya S,
Holzgreve A, Ruf VC, et al: Remote neuroinflammation in newly
diagnosed glioblastoma correlates with unfavorable clinical
outcome. Clin Cancer Res. 30:4618–4634. 2024.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hong DS, Angelo LS and Kurzrock R:
Interleukin-6 and its receptor in cancer: Implications for
translational therapeutics. Cancer. 110:1911–1128. 2007.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Shan Y, He X, Song W, Han D, Niu J and
Wang J: Role of IL-6 in the invasiveness and prognosis of glioma.
Int J Clin Exp Med. 8:9114–9120. 2015.PubMed/NCBI
|
|
42
|
Cao F, Zhang Q, Chen W, Han C, He Y, Ran Q
and Yao S: IL-6 increases SDCBP expression, cell proliferation, and
cell invasion by activating JAK2/STAT3 in human glioma cells. Am J
Transl Res. 9:4617–4626. 2017.PubMed/NCBI
|
|
43
|
Alapirtti T, Lehtimäki K, Nieminen R,
Mäkinen R, Raitanen J, Moilanen E, Mäkinen J and Peltola J: The
production of IL-6 in acute epileptic seizure: A video-EEG study. J
Neuroimmunol. 316:50–55. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
M Taalab Y, Mohammed WF, Helmy MA, Othman
AAA, Darwish M, Hassan I and Abbas M: Cannabis influences the
putative cytokines-related pathway of epilepsy among egyptian
epileptic patients. Brain Sci. 9(332)2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhang Q, Tuerxun N and Tuerxun S: IL-6 is
associated with poor seizure control in low-grade glioma patients
undergoing primary resection. iScience. 27(110267)2024.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Cobbs CS, Harkins L, Samanta M, Gillespie
GY, Bharara S, King PH, Nabors LB, Cobbs CG and Britt WJ: Human
cytomegalovirus infection and expression in human malignant glioma.
Cancer Res. 62:3347–3350. 2002.PubMed/NCBI
|
|
47
|
Rahbar A, Stragliotto G, Orrego A, Peredo
I, Taher C, Willems J and Söderberg-Naucler C: Low levels of Human
Cytomegalovirus Infection in Glioblastoma multiforme associates
with patient survival; -a case-control study. Herpesviridae.
3(3)2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Rahbar A, Orrego A, Peredo I, Dzabic M,
Wolmer-Solberg N, Strååt K, Stragliotto G and Söderberg-Nauclér C:
Human cytomegalovirus infection levels in glioblastoma multiforme
are of prognostic value for survival. J Clin Virol. 57:36–42.
2013.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Pantalone MR, Rahbar A, Söderberg-Naucler
C and Stragliotto G: Valganciclovir as Add-on to Second-Line
therapy in patients with recurrent glioblastoma. Cancers (Basel).
14(1958)2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Stragliotto G, Pantalone MR, Rahbar A,
Bartek J and Söderberg-Naucler C: Valganciclovir as add-on to
standard therapy in glioblastoma patients. Clin Cancer Res.
26:4031–4039. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Stragliotto G, Pantalone MR, Rahbar A and
Söderberg-Nauclér C: Valganciclovir as add-on to standard therapy
in secondary glioblastoma. Microorganisms. 8(1471)2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
De la Cerda-Vargas MF, Pantalone MR,
Söderberg Nauclér C, Medrano-Guzman R, Jauregui Renaud K, Nettel
Rueda B, Reynoso-Sanchez MJ, Lopez-Quintana B, Rodriguez-Florido
MA, Feria-Romero IA, et al: Focal-to-bilateral tonic-clonic
seizures and High-grade CMV-infection are poor survival predictors
in Tumor-related Epilepsy Adult-type diffuse gliomas-A
single-center study and literature review. Heliyon.
10(e28555)2024.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Yuen TI, Morokoff AP, Bjorksten A, D'Abaco
G, Paradiso L, Finch S, Wong D, Reid CA, Powell KL, Drummond KJ, et
al: Glutamate is associated with a higher risk of seizures in
patients with gliomas. Neurology. 79:883–889. 2012.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Dahlmanns M, Dahlmanns JK, Savaskan N,
Steiner HH and Yakubov E: Glial Glutamate Transporter-Mediated
Plasticity: System xc-/xCT/SLC7A11 and
EAAT1/2 in Brain Diseases. Front Biosci (Landmark Ed).
28(57)2023.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Sørensen MF, Heimisdóttir SB, Sørensen MD,
Mellegaard CS, Wohlleben H, Kristensen BW and Beier CP: High
expression of cystine-glutamate antiporter xCT (SLC7A11) is an
independent biomarker for epileptic seizures at diagnosis in
glioma. J Neurooncol. 138:49–53. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Tönjes M, Barbus S, Park YJ, Wang W,
Schlotter M, Lindroth AM, Pleier SV, Bai AHC, Karra D, Piro RM, et
al: BCAT1 promotes cell proliferation through amino acid catabolism
in gliomas carrying wild-type IDH1. Nat Med. 19:901–908.
2013.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Zhang B, Chen Y, Shi X, Zhou M, Bao L,
Hatanpaa KJ, Patel T, DeBerardinis RJ, Wang Y and Luo W: Regulation
of branched-chain amino acid metabolism by hypoxia-inducible factor
in glioblastoma. Cell Mol Life Sci. 78:195–206. 2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada
N, Hagimura N, Okado H, Miwa A, Kurihara H, Nakazato Y, Tamura M,
et al: Blockage of Ca(2+)-permeable AMPA receptors suppresses
migration and induces apoptosis in human glioblastoma cells. Nat
Med. 8:971–978. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
59
|
Liu QS, Xu Q, Arcuino G, Kang J and
Nedergaard M: Astrocyte-mediated activation of neuronal kainate
receptors. Proc Natl Acad Sci USA. 101:3172–3177. 2004.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Gao X, Wang H, Cai S, Saadatzadeh MR,
Hanenberg H, Pollok KE, Cohen-Gadol AA and Chen J: Phosphorylation
of NMDA 2B at S1303 in human glioma peritumoral tissue:
implications for glioma epileptogenesis. Neurosurg Focus.
37(E17)2014.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Wirsching HG, Silginer M, Ventura E,
Macnair W, Burghardt I, Claassen M, Gatti S, Wichmann J, Riemer C,
Schneider H and Weller M: Negative allosteric modulators of
metabotropic glutamate receptor 3 target the stem-like phenotype of
glioblastoma. Mol Ther Oncolytics. 20:166–174. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Ciceroni C, Bonelli M, Mastrantoni E,
Niccolini C, Laurenza M, Larocca LM, Pallini R, Traficante A,
Spinsanti P, Ricci-Vitiani L, et al: Type-3 metabotropic glutamate
receptors regulate chemoresistance in glioma stem cells, and their
levels are inversely related to survival in patients with malignant
gliomas. Cell Death Differ. 20:396–407. 2013.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Zhang Z, Zheng X, Luan Y and Liu Y, Li X,
Liu C, Lu H, Chen X and Liu Y: Activity of metabotropic glutamate
receptor 4 suppresses proliferation and promotes apoptosis with
inhibition of Gli-1 in human glioblastoma cells. Front Neurosci.
12(320)2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Campbell SL, Robel S, Cuddapah VA, Robert
S, Buckingham SC, Kahle KT and Sontheimer H: GABAergic
disinhibition and impaired KCC2 cotransporter activity underlie
tumor-associated epilepsy. Glia. 63:23–36. 2015.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Conti L, Palma E, Roseti C, Lauro C,
Cipriani R, de Groot M, Aronica E and Limatola C: Anomalous levels
of Cl-transporters cause a decrease of GABAergic inhibition in
human peritumoral epileptic cortex. Epilepsia. 52:1635–1644.
2011.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Pallud J, Le Van Quyen M, Bielle F,
Pellegrino C, Varlet P, Cresto N, Baulac M, Duyckaerts C,
Kourdougli N, Chazal G, et al: Cortical GABAergic excitation
contributes to epileptic activities around human glioma. Sci Transl
Med. 6(244ra89)2014.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Elias AF, Lin BC and Piggott BJ: Ion
Channels in Gliomas-From Molecular Basis to Treatment. Int J Mol
Sci. 24(2530)2023.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Curry RN, Aiba I, Meyer J, Lozzi B, Ko Y,
McDonald MF, Rosenbaum A, Cervantes A, Huang-Hobbs E, Cocito C, et
al: Glioma epileptiform activity and progression are driven by
IGSF3-mediated potassium dysregulation. Neuron. 111:682–695.e9.
2023.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Chen H, Judkins J, Thomas C, Wu M, Khoury
L, Benjamin CG, Pacione D, Golfinos JG, Kumthekar P, Ghamsari F, et
al: Mutant IDH1 and seizures in patients with glioma. Neurology.
88:1805–1813. 2017.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Neal A, Kwan P, O'Brien TJ, Buckland ME,
Gonzales M and Morokoff A: IDH1 and IDH2 mutations in postoperative
diffuse glioma-associated epilepsy. Epilepsy Behav. 78:30–36.
2018.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Stockhammer F, Misch M, Helms HJ, Lengler
U, Prall F, von Deimling A and Hartmann C: IDH1/2 mutations in WHO
grade II astrocytomas associated with localization and seizure as
the initial symptom. Seizure. 21:194–197. 2012.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Snijders TJ, Berendsen S, Seute T and Robe
PA: Glioma-associated epilepsy: Toward mechanism-based treatment.
Transl Cancer Res. 6 (Suppl 2):S337–S341. 2017.
|
|
73
|
You G, Huang L, Yang P, Zhang W, Yan W,
Wang Y, Bao Z, Li S, Li S, Li G and Jiang T: Clinical and molecular
genetic factors affecting postoperative seizure control of 183
Chinese adult patients with low-grade gliomas. Eur J Neurol.
19:298–306. 2012.PubMed/NCBI View Article : Google Scholar
|
|
74
|
You G, Sha ZY, Yan W, Zhang W, Wang YZ, Li
SW, Sang L, Wang Z, Li GL, Li SW, et al: Seizure characteristics
and outcomes in 508 Chinese adult patients undergoing primary
resection of low-grade gliomas: A clinicopathological study. Neuro
Oncol. 14:230–241. 2012.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Feyissa AM, Worrell GA, Tatum WO,
Chaichana KL, Jentoft ME, Guerrero Cazares H, Ertekin-Taner N,
Rosenfeld SS, ReFaey K and Quinones-Hinojosa A: Potential influence
of IDH1 mutation and MGMT gene promoter methylation on
glioma-related preoperative seizures and postoperative seizure
control. Seizure. 69:283–289. 2019.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Pan SP, Zheng XL, Zhang N, Lin XM, Li KJ,
Xia XF, Zou CL and Zhang WY: A novel nomogram for predicting the
risk of epilepsy occurrence after operative in gliomas patients
without preoperative epilepsy history. Epilepsy Res.
174(106641)2021.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Yan H, Parsons DW, Jin G, McLendon R,
Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ,
et al: IDH1 and IDH2 mutations in gliomas. N Engl J Med.
360:765–773. 2009.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Hartmann C, Meyer J, Balss J, Capper D,
Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, et
al: Type and frequency of IDH1 and IDH2 mutations are related to
astrocytic and oligodendroglial differentiation and age: A study of
1,010 diffuse gliomas. Acta Neuropathol. 118:469–474.
2009.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Mardis ER, Ding L, Dooling DJ, Larson DE,
McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath
SD, et al: Recurring mutations found by sequencing an acute myeloid
leukemia genome. N Engl J Med. 361:1058–1066. 2009.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Cancer Genome Atlas Research Network. Ley
TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, Hoadley
K, Triche TJ Jr, Laird PW, et al: Genomic and epigenomic landscapes
of adult de novo acute myeloid leukemia. N Engl J Med.
368:2059–2074. 2013.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Marcucci G, Maharry K, Wu YZ, Radmacher
MD, Mrózek K, Margeson D, Holland KB, Whitman SP, Becker H, Schwind
S, et al: IDH1 and IDH2 gene mutations identify novel molecular
subsets within de novo cytogenetically normal acute myeloid
leukemia: A Cancer and Leukemia Group B study. J Clin Oncol.
28:2348–2355. 2010.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Soeung V, Puchalski RB and Noebels JL: The
complex molecular epileptogenesis landscape of glioblastoma. Cell
Rep Med. 5(101691)2024.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Drumm MR, Wang W, Sears TK, Bell-Burdett
K, Javier R, Cotton KY, Webb B, Byrne K, Unruh D, Thirunavu V, et
al: Postoperative risk of IDH-mutant glioma-associated seizures and
their potential management with IDH-mutant inhibitors. J Clin
Invest. 133(e168035)2023.PubMed/NCBI View Article : Google Scholar
|
|
84
|
van Opijnen MP, Tesileanu CMS, Dirven L,
van der Meer PB, Wijnenga MMJ, Vincent AJPE, Broekman MLD, Dubbink
HJ, Kros JM, van Duinen SG, et al: IDH1/2 wildtype gliomas grade 2
and 3 with molecular glioblastoma-like profile have a distinct
course of epilepsy compared to IDH1/2 wildtype glioblastomas. Neuro
Oncol. 25:701–709. 2023.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Tang T, Wang Y, Dai Y, Liu Q, Fan X, Cheng
Y, Tang J, Xiao X, Shan Y, Wei P and Zhao G: IDH1 mutation predicts
seizure occurrence and prognosis in lower-grade glioma adults.
Pathol Res Pract. 254(155165)2024.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Skardelly M, Brendle E, Noell S, Behling
F, Wuttke TV, Schittenhelm J, Bisdas S, Meisner C, Rona S, Tatagiba
MS and Tabatabai G: Predictors of preoperative and early
postoperative seizures in patients with intra-axial primary and
metastatic brain tumors: A retrospective observational single
center study. Ann Neurol. 78:917–928. 2015.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Song L, Quan X, Chen C, Chen L and Zhou J:
Correlation between tumor molecular markers and perioperative
epilepsy in patients with glioma: A systematic review and
meta-analysis. Front Neurol. 12(692751)2021.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Shen S, Bai Y, Zhang B, Liu T, Yu X and
Feng S: Correlation of preoperative seizures with a wide range of
tumor molecular markers in gliomas: An analysis of 442 glioma
patients from China. Epilepsy Res. 166(106430)2020.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Bruno F, Pellerino A, Conti Nibali M,
Pronello E, Cofano F, Rossi M, Levis M, Bertero L, Soffietti R,
Cassoni P, et al: Association of clinical, tumor, and treatment
characteristics with seizure control in patients with IDH1/2-Mutant
Lower-Grade Glioma. Neurology. 102(e209352)2024.PubMed/NCBI View Article : Google Scholar
|
|
90
|
McAfee D, Moyer M, Queen J, Mortazavi A,
Boddeti U, Bachani M, Zaghloul K and Ksendzovsky A: Differential
metabolic alterations in IDH1 mutant vs. wildtype glioma cells
promote epileptogenesis through distinctive mechanisms. Front Cell
Neurosci. 17(1288918)2023.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Nagashima H, Tanaka K, Yamanishi S,
Hashiguchi M, Iwahashi H, Uno T, Somiya Y, Komatsu M, Itoh T,
Sasaki R and Sasayama T: Association between accumulation of
2-hydroxyglutarate detected by MR spectroscopy and preoperative
seizure in IDH-mutant glioma. J Neurosurg. 142:712–721.
2024.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Kölker S, Pawlak V, Ahlemeyer B, Okun JG,
Hörster F, Mayatepek E, Krieglstein J, Hoffmann GF and Köhr G: NMDA
receptor activation and respiratory chain complex V inhibition
contribute to neurodegeneration in d-2-hydroxyglutaric aciduria.
Eur J Neurosci. 16:21–28. 2002.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Junqueira D, Brusque AM, Porciúncula LO,
Rotta LN, Frizzo ME, Wyse AT, Wannmacher CM, Souza DO and Wajner M:
In vitro effects of D-2-hydroxyglutaric acid on glutamate binding,
uptake and release in cerebral cortex of rats. J Neurol Sci.
217:189–194. 2004.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Yamamoto HA and Mohanan PV: Effect of
alpha-ketoglutarate and oxaloacetate on brain mitochondrial DNA
damage and seizures induced by kainic acid in mice. Toxicol Lett.
143:115–122. 2003.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim
SH, Ito S, Yang C, Wang P, Xiao MT, et al: Oncometabolite
2-hydroxyglutarate is a competitive inhibitor of
alpha-ketoglutarate-dependent dioxygenases. Cancer Cell. 19:17–30.
2011.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Stella M, Baiardi G, Pasquariello S, Sacco
F, Dellacasagrande I, Corsaro A, Mattioli F and Barbieri F:
Antitumor potential of antiepileptic drugs in human glioblastoma:
Pharmacological targets and clinical benefits. Biomedicines.
11(582)2023.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Winkler F: Understanding epilepsy in
IDH-mutated gliomas: Towards a targeted therapy. Neuro Oncol.
24:1436–1437. 2022.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Mortazavi A, Fayed I, Bachani M, Dowdy T,
Jahanipour J, Khan A, Owotade J, Walbridge S, Inati SK, Steiner J,
et al: IDH-mutated gliomas promote epileptogenesis through
d-2-hydroxyglutarate-dependent mTOR hyperactivation. Neuro Oncol.
24:1423–1435. 2022.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Boison D: Role of adenosine in status
epilepticus: A potential new target? Epilepsia. 54 (Suppl
6):S20–S22. 2013.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Boison D: Adenosine and seizure
termination: Endogenous mechanisms. Epilepsy Curr. 13:35–37.
2013.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Hargus NJ, Jennings C, Perez-Reyes E,
Bertram EH and Patel MK: Enhanced actions of adenosine in medial
entorhinal cortex layer II stellate neurons in temporal lobe
epilepsy are mediated via A(1)-receptor activation. Epilepsia.
53:168–176. 2012.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Świąder MJ, Kotowski J and Łuszczki JJ:
Modulation of adenosinergic system and its application for the
treatment of epilepsy. Pharmacol Rep. 66:335–342. 2014.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Boison D: Adenosine kinase: Exploitation
for therapeutic gain. Pharmacol Rev. 65:906–943. 2013.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Siebel AM, Piato AL, Schaefer IC, Nery LR,
Bogo MR and Bonan CD: Antiepileptic drugs prevent changes in
adenosine deamination during acute seizure episodes in adult
zebrafish. Pharmacol Biochem Behav. 104:20–26. 2013.PubMed/NCBI View Article : Google Scholar
|
|
105
|
de Groot M, Iyer A, Zurolo E, Anink J,
Heimans JJ, Boison D, Reijneveld JC and Aronica E: Overexpression
of ADK in human astrocytic tumors and peritumoral tissue is related
to tumor-associated epilepsy. Epilepsia. 53:58–66. 2012.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Huang J, He Y, Chen M, Du J, Li G, Li S,
Liu W and Long X: Adenosine deaminase and adenosine kinase
expression in human glioma and their correlation with
glioma-associated epilepsy. Mol Med Rep. 12:6509–6516.
2015.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Pence S, Erkutlu I, Kurtul N, Bosnak M,
Alptekin M and Tan U: Antiepileptogenic effects of glutathione
against increased brain ADA in PTZ-induced epilepsy. Int J
Neurosci. 119:616–629. 2009.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Shen HY, Sun H, Hanthorn MM, Zhi Z, Lan
JQ, Poulsen DJ, Wang RK and Boison D: Overexpression of adenosine
kinase in cortical astrocytes and focal neocortical epilepsy in
mice. J Neurosurg. 120:628–638. 2014.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Boison D: Adenosine dysfunction and
adenosine kinase in epileptogenesis. Open Neurosci J. 4:93–101.
2010.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Wang SI, Puc J, Li J, Bruce JN, Cairns P,
Sidransky D and Parsons R: Somatic mutations of PTEN in
glioblastoma multiforme. Cancer Res. 57:4183–4186. 1997.PubMed/NCBI
|
|
111
|
Han F, Hu R, Yang H, Liu J, Sui J, Xiang
X, Wang F, Chu L and Song S: PTEN gene mutations correlate to poor
prognosis in glioma patients: A meta-analysis. Onco Targets Ther.
9:3485–3492. 2016.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Pearson JRD and Regad T: Targeting
cellular pathways in glioblastoma multiforme. Signal Transduct
Target Ther. 2(17040)2017.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Soomro SH, Ting LR, Qing YY and Ren M:
Molecular biology of glioblastoma: Classification and mutational
locations. J Pak Med Assoc. 67:1410–1414. 2017.PubMed/NCBI
|
|
114
|
Szopa W, Burley TA, Kramer-Marek G and
Kaspera W: Diagnostic and therapeutic biomarkers in glioblastoma:
Current status and future perspectives. Biomed Res Int.
2017(8013575)2017.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Dittmer D, Pati S, Zambetti G, Chu S,
Teresky AK, Moore M, Finlay C and Levine AJ: Gain of function
mutations in p53. Nat Genet. 4:42–46. 1993.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Nagpal J, Jamoona A, Gulati ND, Mohan A,
Braun A, Murali R and Jhanwar-Uniyal M: Revisiting the role of p53
in primary and secondary glioblastomas. Anticancer Res. 26
(6C):4633–4639. 2006.PubMed/NCBI
|
|
117
|
Zhang Y, Dube C, Gibert M Jr, Cruickshanks
N, Wang B, Coughlan M, Yang Y, Setiady I, Deveau C, Saoud K, et al:
The p53 Pathway in Glioblastoma. Cancers (Basel).
10(297)2018.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Hatcher A, Yu K, Meyer J, Aiba I, Deneen B
and Noebels JL: Pathogenesis of peritumoral hyperexcitability in an
immunocompetent CRISPR-based glioblastoma model. J Clin Invest.
130:2286–2300. 2020.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Hu S, Kao HY, Yang T and Wang Y: Early and
Bi-hemispheric seizure onset in a rat glioblastoma Multiforme
model. Neurosci Lett. 766(136351)2022.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Endersby R and Baker SJ: PTEN signaling in
brain: Neuropathology and tumorigenesis. Oncogene. 27:5416–5430.
2008.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Venkatesan S, Lamfers ML, Dirven CM and
Leenstra S: Genetic biomarkers of drug response for small-molecule
therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in
glioblastoma. CNS Oncol. 5:77–90. 2016.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Nishio S, Morioka T, Hisada K and Fukui M:
Temporal lobe epilepsy: A clinicopathological study with special
reference to temporal neocortical changes. Neurosurg Rev. 23:84–89.
2000.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Backman SA, Stambolic V, Suzuki A, Haight
J, Elia A, Pretorius J, Tsao MS, Shannon P, Bolon B, Ivy GO and Mak
TW: Deletion of Pten in mouse brain causes seizures, ataxia and
defects in soma size resembling Lhermitte-Duclos disease. Nat
Genet. 29:396–403. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
124
|
Luikart BW, Schnell E, Washburn EK, Bensen
AL, Tovar KR and Westbrook GL: Pten knockdown in vivo increases
excitatory drive onto dentate granule cells. J Neurosci.
31:4345–4354. 2011.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Williams MR, DeSpenza T Jr, Li M, Gulledge
AT and Luikart BW: Hyperactivity of newborn Pten knock-out neurons
results from increased excitatory synaptic drive. J Neurosci.
35:943–959. 2015.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Pun RY, Rolle IJ, Lasarge CL, Hosford BE,
Rosen JM, Uhl JD, Schmeltzer SN, Faulkner C, Bronson SL, Murphy BL,
et al: Excessive activation of mTOR in postnatally generated
granule cells is sufficient to cause epilepsy. Neuron.
75:1022–1034. 2012.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Sabetghadam A, Wu C, Liu J, Zhang L and
Reid AY: Increased epileptogenicity in a mouse model of
neurofibromatosis type 1. Exp Neurol. 331(113373)2020.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Sorrentino U, Bellonzi S, Mozzato C,
Brasson V, Toldo I, Parrozzani R, Clementi M, Cassina M and
Trevisson E: Epilepsy in NF1: Epidemiologic, genetic, and clinical
features. A monocentric retrospective study in a cohort of 784
patients. Cancers (Basel). 13(6336)2021.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Kastenhuber ER and Lowe SW: Putting p53 in
Context. Cell. 170:1062–1078. 2017.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Choi BD, Lee DK, Yang JC, Ayinon CM, Lee
CK, Maus D, Carter BS, Barker FG, Jones PS, Nahed BV, et al:
Receptor tyrosine kinase gene amplification is predictive of
intraoperative seizures during glioma resection with functional
mapping. J Neurosurg. 132:1017–1023. 2020.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Fredriksson L, Stevenson TK, Su EJ,
Ragsdale M, Moore S, Craciun S, Schielke GP, Murphy GG and Lawrence
DA: Identification of a neurovascular signaling pathway regulating
seizures in mice. Ann Clin Transl Neurol. 2:722–738.
2015.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Yang P, You G, Zhang W, Wang Y, Wang Y,
Yao K and Jiang T: Correlation of preoperative seizures with
clinicopathological factors and prognosis in anaplastic gliomas: A
report of 198 patients from China. Seizure. 23:844–851.
2014.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Szelényi A, Joksimovic B and Seifert V:
Intraoperative risk of seizures associated with transient direct
cortical stimulation in patients with symptomatic epilepsy. J Clin
Neurophysiol. 24:39–43. 2007.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Tsuchihashi K, Okazaki S, Ohmura M,
Ishikawa M, Sampetrean O, Onishi N, Wakimoto H, Yoshikawa M,
Seishima R, Iwasaki Y, et al: The EGF receptor promotes the
malignant potential of glioma by regulating amino acid transport
system xc(-). Cancer Res. 76:2954–2963. 2016.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Morrison RS, Wenzel HJ, Kinoshita Y,
Robbins CA, Donehower LA and Schwartzkroin PA: Loss of the p53
tumor suppressor gene protects neurons from kainate-induced cell
death. J Neurosci. 16:1337–1345. 1996.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Engel T, Murphy BM, Schindler CK and
Henshall DC: Elevated p53 and lower MDM2 expression in hippocampus
from patients with intractable temporal lobe epilepsy. Epilepsy
Res. 77:151–156. 2007.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Toledo M, Sarria-Estrada S, Quintana M,
Maldonado X, Martinez-Ricarte F, Rodon J, Auger C, Aizpurua M,
Salas-Puig J, Santamarina E and Martinez-Saez E: Epileptic features
and survival in glioblastomas presenting with seizures. Epilepsy
Res. 130:1–6. 2017.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Suzuki H, Mikuni N, Sugita S, Aoyama T,
Yokoyama R, Suzuki Y, Enatsu R, Akiyama Y, Mikami T, Wanibuchi M
and Hasegawa T: Molecular aberrations associated with seizure
control in diffuse astrocytic and oligodendroglial tumors. Neurol
Med Chir (Tokyo). 60:147–155. 2020.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Zheng H, Ying H, Yan H, Kimmelman AC,
Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, et al: p53
and Pten control neural and glioma stem/progenitor cell renewal and
differentiation. Nature. 455:1129–1133. 2008.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Fontana L, Tabano S, Bonaparte E, Marfia
G, Pesenti C, Falcone R, Augello C, Carlessi N, Silipigni R,
Guerneri S, et al: MGMT-methylated alleles are distributed
heterogeneously within glioma samples irrespective of IDH status
and chromosome 10q deletion. J Neuropathol Exp Neurol. 75:791–800.
2016.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Stichel D, Ebrahimi A, Reuss D, Schrimpf
D, Ono T, Shirahata M, Reifenberger G, Weller M, Hänggi D, Wick W,
et al: Distribution of EGFR amplification, combined chromosome 7
gain and chromosome 10 loss, and TERT promoter mutation in brain
tumors and their potential for the reclassification of IDHwt
astrocytoma to glioblastoma. Acta Neuropathol. 136:793–803.
2018.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Saviuk M, Sleptsova E, Redkin T and
Turubanova V: Unexplained causes of glioma-associated epilepsies: A
review of theories and an area for research. Cancers (Basel).
15(5539)2023.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Mortazavi A, Khan AU, Nieblas-Bedolla E,
Boddeti U, Bachani M, Ksendzovsky A, Johnson K and Zaghloul KA:
Differential gene expression underlying epileptogenicity in
patients with gliomas. Neurooncol Adv. 6(vdae103)2024.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Phabphal K, Kaewborisutsakul A,
Leetanaporn K, Choochuen P, Tunthanathip T, Navakanitworakul R and
Sangkhathat S: Gene mutations linked to drug-resistant epilepsy in
astrocytoma. Front Neurol. 16(1523468)2025.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Hu F, Ku MC, Markovic D, Dzaye O, Lehnardt
S, Synowitz M, Wolf SA and Kettenmann H: Glioma-associated
microglial MMP9 expression is upregulated by TLR2 signaling and
sensitive to minocycline. Int J Cancer. 135:2569–2578.
2014.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Koyama R, Yamada MK, Fujisawa S,
Katoh-Semba R, Matsuki N and Ikegaya Y: Brain-derived neurotrophic
factor induces hyperexcitable reentrant circuits in the dentate
gyrus. J Neurosci. 24:7215–7224. 2004.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Young SZ and Bordey A: GABA's control of
stem and cancer cell proliferation in adult neural and peripheral
niches. Physiology (Bethesda). 24:171–185. 2009.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Rubinov M and Sporns O: Complex network
measures of brain connectivity: Uses and interpretations.
Neuroimage. 52:1059–1069. 2010.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Bullmore E and Sporns O: Complex brain
networks: Graph theoretical analysis of structural and functional
systems. Nat Rev Neurosci. 10:186–198. 2009.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Franaszczuk PJ and Bergey GK: Application
of the directed transfer function method to mesial and lateral
onset temporal lobe seizures. Brain Topogr. 11:13–21.
1998.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Kramer MA, Kolaczyk ED and Kirsch HE:
Emergent network topology at seizure onset in humans. Epilepsy Res.
79:173–186. 2008.PubMed/NCBI View Article : Google Scholar
|
|
152
|
Percha B, Dzakpasu R, Zochowski M and
Parent J: Transition from local to global phase synchrony in small
world neural network and its possible implications for epilepsy.
Phys Rev E Stat Nonlin Soft Matter Phys. 72 (3 Pt
1)(031909)2005.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Morgan RJ and Soltesz I: Nonrandom
connectivity of the epileptic dentate gyrus predicts a major role
for neuronal hubs in seizures. Proc Natl Acad Sci USA.
105:6179–6184. 2008.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Bartolomei F, Bosma I, Klein M, Baayen JC,
Reijneveld JC, Postma TJ, Heimans JJ, van Dijk BW, de Munck JC, de
Jongh A, et al: Disturbed functional connectivity in brain tumour
patients: Evaluation by graph analysis of synchronization matrices.
Clin Neurophysiol. 117:2039–2049. 2006.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Bartolomei F, Bosma I, Klein M, Baayen JC,
Reijneveld JC, Postma TJ, Heimans JJ, van Dijk BW, de Munck JC, de
Jongh A, et al: How do brain tumors alter functional connectivity?
A magnetoencephalography study. Ann Neurol. 59:128–138.
2006.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Douw L, de Groot M, van Dellen E, Aronica
E, Heimans JJ, Klein M, Stam CJ, Reijneveld JC and Hillebrand A:
Local MEG networks: the missing link between protein expression and
epilepsy in glioma patients? Neuroimage. 75:195–203.
2013.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Douw L, van Dellen E, de Groot M, Heimans
JJ, Klein M, Stam CJ and Reijneveld JC: Epilepsy is related to
theta band brain connectivity and network topology in brain tumor
patients. BMC Neurosci. 11(103)2010.PubMed/NCBI View Article : Google Scholar
|
|
158
|
You G, Sha Z and Jiang T: Clinical
diagnosis and perioperative management of glioma-related epilepsy.
Front Oncol. 10(550353)2020.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Liang S, Fan X, Chen F, Liu Y, Qiu B,
Zhang K, Qi S, Zhang G, Liu J, Zhang J, et al: Chinese guideline on
the application of anti-seizure medications in the perioperative
period of supratentorial craniocerebral surgery. Ther Adv Neurol
Disord. 15(17562864221114357)2022.PubMed/NCBI View Article : Google Scholar
|
|
160
|
Ollila L and Roivainen R: Glioma features
and seizure control during long-term follow-up. Epilepsy Behav Rep.
21(100586)2023.PubMed/NCBI View Article : Google Scholar
|
|
161
|
de Bruin ME, van der Meer PB, Dirven L,
Taphoorn MJB and Koekkoek JAF: Efficacy of antiepileptic drugs in
glioma patients with epilepsy: A systematic review. Neurooncol
Pract. 8:501–517. 2021.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Bobustuc GC, Baker CH, Limaye A, Jenkins
WD, Pearl G, Avgeropoulos NG and Konduri SD: Levetiracetam enhances
p53-mediated MGMT inhibition and sensitizes glioblastoma cells to
temozolomide. Neuro Oncol. 12:917–927. 2010.PubMed/NCBI View Article : Google Scholar
|
|
163
|
Tabaee Damavandi P, Pasini F, Fanella G,
Cereda GS, Mainini G, DiFrancesco JC, Trinka E and Lattanzi S:
Perampanel in brain tumor-related epilepsy: A systematic review.
Brain Sci. 13(326)2023.PubMed/NCBI View Article : Google Scholar
|
|
164
|
Rossi J, Cavallieri F, Bassi MC, Biagini
G, Rizzi R, Russo M, Bondavalli M, Iaccarino C, Pavesi G, Cozzi S,
et al: Efficacy and tolerability of perampanel in brain
tumor-related epilepsy: A systematic review. Biomedicines.
11(651)2023.PubMed/NCBI View Article : Google Scholar
|
|
165
|
Correia CE, Umemura Y, Flynn JR, Reiner AS
and Avila EK: Pharmacoresistant seizures and IDH mutation in
low-grade gliomas. Neurooncol Adv. 3(vdab146)2021.PubMed/NCBI View Article : Google Scholar
|
|
166
|
Lim DA, Tarapore P, Chang E, Burt M,
Chakalian L, Barbaro N, Chang S, Lamborn KR and McDermott MW:
Safety and feasibility of switching from phenytoin to levetiracetam
monotherapy for glioma-related seizure control following
craniotomy: A randomized phase II pilot study. J Neurooncol.
93:349–354. 2009.PubMed/NCBI View Article : Google Scholar
|
|
167
|
Iuchi T, Kuwabara K, Matsumoto M, Kawasaki
K, Hasegawa Y and Sakaida T: Levetiracetam versus phenytoin for
seizure prophylaxis during and early after craniotomy for brain
tumours: A phase II prospective, randomised study. J Neurol
Neurosurg Psychiatry. 86:1158–1162. 2015.PubMed/NCBI View Article : Google Scholar
|
|
168
|
Kerkhof M, Dielemans JC, van Breemen MS,
Zwinkels H, Walchenbach R, Taphoorn MJ and Vecht CJ: Effect of
valproic acid on seizure control and on survival in patients with
glioblastoma multiforme. Neuro Oncol. 15:961–967. 2013.PubMed/NCBI View Article : Google Scholar
|
|
169
|
Weller M, Gorlia T, Cairncross JG, van den
Bent MJ, Mason W, Belanger K, Brandes AA, Bogdahn U, Macdonald DR,
Forsyth P, et al: Prolonged survival with valproic acid use in the
EORTC/NCIC temozolomide trial for glioblastoma. Neurology.
77:1156–1164. 2011.PubMed/NCBI View Article : Google Scholar
|
|
170
|
Pak O, Kosianova A, Zaitsev S, Sharma A,
Sharma H and Bryukhovetskiy I: Valproic acid and celecoxib enhance
the effect of temozolomide on glioblastoma cells. CNS Neurol Disord
Drug Targets. 24:375–381. 2025.PubMed/NCBI View Article : Google Scholar
|
|
171
|
Salmaggi A, Corno C, Maschio M, Donzelli
S, D'Urso A, Perego P and Ciusani E: Synergistic effect of
perampanel and temozolomide in human glioma cell lines. J Pers Med.
11(390)2021.PubMed/NCBI View Article : Google Scholar
|
|
172
|
Nishide T, Yamamuro S, Sano E, Aida Y,
Nara K, Yazama G, Ozawa Y and Yoshino A: Synergistic effect of
perampanel with temozolomide on glioblastoma cells in vivo.
Heliyon. 11(e43167)2025.
|
|
173
|
Vecht C, Royer-Perron L, Houillier C and
Huberfeld G: Seizures and anticonvulsants in brain tumours:
Frequency, mechanisms and anti-epileptic management. Curr Pharm
Des. 23:6464–6487. 2017.PubMed/NCBI View Article : Google Scholar
|
|
174
|
Simó M, Velasco R, Graus F, Verger E, Gil
M, Pineda E, Blasco J and Bruna J: Impact of antiepileptic drugs on
thrombocytopenia in glioblastoma patients treated with standard
chemoradiotherapy. J Neurooncol. 108:451–458. 2012.PubMed/NCBI View Article : Google Scholar
|
|
175
|
Li C, Chen H, Tan Q, Xie C, Zhan W, Sharma
A, Sharma HS and Zhang Z: The therapeutic and neuroprotective
effects of an antiepileptic drug valproic acid in glioma patients.
Prog Brain Res. 258:369–379. 2020.PubMed/NCBI View Article : Google Scholar
|
|
176
|
Thotala D, Karvas RM, Engelbach JA, Garbow
JR, Hallahan AN, DeWees TA, Laszlo A and Hallahan DE: Valproic acid
enhances the efficacy of radiation therapy by protecting normal
hippocampal neurons and sensitizing malignant glioblastoma cells.
Oncotarget. 6:35004–35022. 2015.PubMed/NCBI View Article : Google Scholar
|
|
177
|
Lee PY, Wei YT, Chao KC, Chu CN, Chung WH
and Wang TH: Anti-epileptic drug use during adjuvant
chemo-radiotherapy is associated with poorer survival in patients
with glioblastoma: A nationwide population-based cohort study. J
Cancer Res Ther. 20:555–562. 2024.PubMed/NCBI View Article : Google Scholar
|
|
178
|
Walbert T, Harrison RA, Schiff D, Avila
EK, Chen M, Kandula P, Lee JW, Le Rhun E, Stevens GHJ, Vogelbaum
MA, et al: SNO and EANO practice guideline update: Anticonvulsant
prophylaxis in patients with newly diagnosed brain tumors. Neuro
Oncol. 23:1835–1844. 2021.PubMed/NCBI View Article : Google Scholar
|
|
179
|
Wang X, Zheng X, Hu S, Xing A, Wang Z,
Song Y, Chen J, Tian S, Mao Y and Chi X: Efficacy of perioperative
anticonvulsant prophylaxis in seizure-naïve glioma patients: A
meta-analysis. Clin Neurol Neurosurg. 186(105529)2019.PubMed/NCBI View Article : Google Scholar
|
|
180
|
Youshani AS, Heal C, Lee JX, Younis M,
Mohanraj R, Maye H, Bailey M, Coope D, D'Urso PI and Karabatsou K:
Glioma-related epilepsy following low-grade glioma surgery.
Neurooncol Adv. 6(vdae127)2024.PubMed/NCBI View Article : Google Scholar
|
|
181
|
Stocksdale B, Nagpal S, Hixson JD, Johnson
DR, Rai P, Shivaprasad A and Tremont-Lukats IW: Neuro-oncology
practice clinical debate: Long-term antiepileptic drug prophylaxis
in patients with glioma. Neurooncol Pract. 7:583–588.
2020.PubMed/NCBI View Article : Google Scholar
|
|
182
|
Avila EK, Chamberlain M, Schiff D,
Reijneveld JC, Armstrong TS, Ruda R, Wen PY, Weller M, Koekkoek JA,
Mittal S, et al: Seizure control as a new metric in assessing
efficacy of tumor treatment in low-grade glioma trials. Neuro
Oncol. 19:12–21. 2017.PubMed/NCBI View Article : Google Scholar
|
|
183
|
Koekkoek JA, Kerkhof M, Dirven L, Heimans
JJ, Reijneveld JC and Taphoorn MJ: Seizure outcome after
radiotherapy and chemotherapy in low-grade glioma patients: A
systematic review. Neuro Oncol. 17:924–934. 2015.PubMed/NCBI View Article : Google Scholar
|
|
184
|
Takada S, Iwasaki M, Suzuki H, Nakasato N,
Kumabe T and Tominaga T: Angiocentric glioma and surrounding
cortical dysplasia manifesting as intractable frontal lobe
epilepsy-case report. Neurol Med Chir (Tokyo). 51:522–526.
2011.PubMed/NCBI View Article : Google Scholar
|
|
185
|
Mikuni N, Ikeda A, Takahashi JA, Nozaki K,
Miyamoto S, Taki W and Hashimoto N: A step-by-step resection guided
by electrocorticography for nonmalignant brain tumors associated
with long-term intractable epilepsy. Epilepsy Behav. 8:560–564.
2006.PubMed/NCBI View Article : Google Scholar
|
|
186
|
Dobran M, Nasi D, Chiriatti S, Gladi M,
Somma LD, Iacoangeli M and Scerrati M: Prognostic factors in
glioblastoma: Is there a role for epilepsy? Neurol Med Chir
(Tokyo). 58:110–115. 2018.PubMed/NCBI View Article : Google Scholar
|
|
187
|
Chang EF, Potts MB, Keles GE, Lamborn KR,
Chang SM, Barbaro NM and Berger MS: Seizure characteristics and
control following resection in 332 patients with low-grade gliomas.
J Neurosurg. 108:227–235. 2008.PubMed/NCBI View Article : Google Scholar
|
|
188
|
Englot DJ, Berger MS, Barbaro NM and Chang
EF: Predictors of seizure freedom after resection of supratentorial
low-grade gliomas. A review. J Neurosurg. 115:240–244.
2011.PubMed/NCBI View Article : Google Scholar
|
|
189
|
Hervey-Jumper SL and Berger MS: Insular
glioma surgery: An evolution of thought and practice. J Neurosurg.
130:9–16. 2019.PubMed/NCBI View Article : Google Scholar
|
|
190
|
Zhang JJY, Lee KS, Wang DD, Hervey-Jumper
SL and Berger MS: Seizure outcome after resection of insular
glioma: A systematic review, meta-analysis, and institutional
experience. J Neurosurg. 138:1242–1253. 2022.PubMed/NCBI View Article : Google Scholar
|
|
191
|
Köhling R, Senner V, Paulus W and
Speckmann EJ: Epileptiform activity preferentially arises outside
tumor invasion zone in glioma xenotransplants. Neurobiol Dis.
22:64–75. 2006.PubMed/NCBI View Article : Google Scholar
|
|
192
|
You H and Qiao H: Intraoperative
neuromonitoring during resection of gliomas involving eloquent
areas. Front Neurol. 12(658680)2021.PubMed/NCBI View Article : Google Scholar
|
|
193
|
Saghebdoust S, Dayyani M, Rouhbakhsh
Zahmatkesh MR, Abbasi B, Soltani G and Zare R: Launching awake
craniotomy technique in a resource-limited center: New insights
into the patient experience, costs, and long-term outcomes and a
narrative review of the literature. World Neurosurg.
168:246–257.e4. 2022.PubMed/NCBI View Article : Google Scholar
|
|
194
|
Battista F, Muscas G, Parenti A, Bonaudo
C, Gadda D, Martinelli C, Carrai R, Amadori A, Grippo A and Della
Puppa A: Electrocorticography and navigated transcranial magnetic
stimulation-tailored supratotal resection for epileptogenic
low-grade gliomas. J Neurosurg. 142:918–926. 2024.PubMed/NCBI View Article : Google Scholar
|
|
195
|
Juhász C and Mittal S: Molecular imaging
of brain tumor-associated epilepsy. Diagnostics (Basel).
10(1049)2020.PubMed/NCBI View Article : Google Scholar
|
|
196
|
Ricci R, Bacci A, Tugnoli V, Battaglia S,
Maffei M, Agati R and Leonardi M: Metabolic findings on 3T 1H-MR
spectroscopy in peritumoral brain edema. AJNR Am J Neuroradiol.
28:1287–1291. 2007.PubMed/NCBI View Article : Google Scholar
|
|
197
|
Liubinas SV, Drummond KJ, Desmond PM,
Bjorksten A, Morokoff AP, Kaye AH, O'Brien TJ and Moffat BA:
Glutamate quantification in patients with supratentorial gliomas
using chemical shift imaging. NMR Biomed. 27:570–577.
2014.PubMed/NCBI View Article : Google Scholar
|
|
198
|
Goldenberg JM and Pagel MD: Assessments of
tumor metabolism with CEST MRI. NMR Biomed.
32(e3943)2019.PubMed/NCBI View Article : Google Scholar
|
|
199
|
Simister RJ, McLean MA, Barker GJ and
Duncan JS: Proton MR spectroscopy of metabolite concentrations in
temporal lobe epilepsy and effect of temporal lobe resection.
Epilepsy Res. 83:168–176. 2009.PubMed/NCBI View Article : Google Scholar
|
|
200
|
Rudà R, Magliola U, Bertero L, Trevisan E,
Bosa C, Mantovani C, Ricardi U, Castiglione A, Monagheddu C and
Soffietti R: Seizure control following radiotherapy in patients
with diffuse gliomas: A retrospective study. Neuro Oncol.
15:1739–1749. 2013.PubMed/NCBI View Article : Google Scholar
|
|
201
|
Koekkoek JA, Dirven L, Heimans JJ, Postma
TJ, Vos MJ, Reijneveld JC and Taphoorn MJ: Seizure reduction in a
low-grade glioma: more than a beneficial side effect of
temozolomide. J Neurol Neurosurg Psychiatry. 86:366–373.
2015.PubMed/NCBI View Article : Google Scholar
|
|
202
|
Kahlenberg CA, Fadul CE, Roberts DW,
Thadani VM, Bujarski KA, Scott RC and Jobst BC: Seizure prognosis
of patients with low-grade tumors. Seizure. 21:540–545.
2012.PubMed/NCBI View Article : Google Scholar
|
|
203
|
Pace A, Vidiri A, Galiè E, Carosi M,
Telera S, Cianciulli AM, Canalini P, Giannarelli D, Jandolo B and
Carapella CM: Temozolomide chemotherapy for progressive low-grade
glioma: Clinical benefits and radiological response. Ann Oncol.
14:1722–1726. 2003.PubMed/NCBI View Article : Google Scholar
|
|
204
|
Sherman JH, Moldovan K, Yeoh HK, Starke
RM, Pouratian N, Shaffrey ME and Schiff D: Impact of temozolomide
chemotherapy on seizure frequency in patients with low-grade
gliomas. J Neurosurg. 114:1617–1621. 2011.PubMed/NCBI View Article : Google Scholar
|
|
205
|
Yue J, Yin C, Chen L, Xu R and Zhao D: Is
there a role for temozolomide in glioma related seizures? A
systematic review. Neurol India. 70:864–871. 2022.PubMed/NCBI View Article : Google Scholar
|
|
206
|
Mellinghoff IK, van den Bent MJ,
Blumenthal DT, Touat M, Peters KB, Clarke J, Mendez J, Yust-Katz S,
Welsh L, Mason WP, et al: Vorasidenib in IDH1- or IDH2-Mutant
Low-Grade Glioma. N Engl J Med. 389:589–601. 2023.PubMed/NCBI View Article : Google Scholar
|
|
207
|
Mellinghoff IK, Penas-Prado M, Peters KB,
Burris HA III, Maher EA, Janku F, Cote GM, de la Fuente MI, Clarke
JL, Ellingson BM, et al: Vorasidenib, a dual inhibitor of mutant
IDH1/2, in recurrent or progressive glioma; Results of a
first-in-human phase I trial. Clin Cancer Res. 27:4491–4499.
2021.PubMed/NCBI View Article : Google Scholar
|
|
208
|
Mellinghoff IK, Lu M, Wen PY, Taylor JW,
Maher EA, Arrillaga-Romany I, Peters KB, Ellingson BM, Rosenblum
MK, Chun S, et al: Vorasidenib and ivosidenib in IDH1-mutant
low-grade glioma: A randomized, perioperative phase 1 trial. Nat
Med. 29:615–622. 2023.PubMed/NCBI View Article : Google Scholar
|
|
209
|
Vo AH, Ambady P and Spencer D: The IDH1
inhibitor ivosidenib improved seizures in a patient with
drug-resistant epilepsy from IDH1 mutant oligodendroglioma.
Epilepsy Behav Rep. 18(100526)2022.PubMed/NCBI View Article : Google Scholar
|
|
210
|
Librizzi L, Vila Verde D, Colciaghi F,
Deleo F, Regondi MC, Costanza M, Cipelletti B and de Curtis M:
Peripheral blood mononuclear cell activation sustains seizure
activity. Epilepsia. 62:1715–1728. 2021.PubMed/NCBI View Article : Google Scholar
|
|
211
|
Seiffert E, Dreier JP, Ivens S, Bechmann
I, Tomkins O, Heinemann U and Friedman A: Lasting blood-brain
barrier disruption induces epileptic focus in the rat somatosensory
cortex. J Neurosci. 24:7829–7836. 2004.PubMed/NCBI View Article : Google Scholar
|
|
212
|
Marchi N, Angelov L, Masaryk T, Fazio V,
Granata T, Hernandez N, Hallene K, Diglaw T, Franic L, Najm I and
Janigro D: Seizure-promoting effect of blood-brain barrier
disruption. Epilepsia. 48:732–742. 2007.PubMed/NCBI View Article : Google Scholar
|
|
213
|
Xu D, Miller SD and Koh S: Immune
mechanisms in epileptogenesis. Front Cell Neurosci.
7(195)2013.PubMed/NCBI View Article : Google Scholar
|
|
214
|
van Vliet EA, da Costa Araújo S, Redeker
S, van Schaik R, Aronica E and Gorter JA: Blood-brain barrier
leakage may lead to progression of temporal lobe epilepsy. Brain.
130 (Pt 2):521–534. 2007.PubMed/NCBI View Article : Google Scholar
|
|
215
|
Xu D, Robinson AP, Ishii T, Duncan DS,
Alden TD, Goings GE, Ifergan I, Podojil JR, Penaloza-MacMaster P,
Kearney JA, et al: Peripherally derived T regulatory and γδ T cells
have opposing roles in the pathogenesis of intractable pediatric
epilepsy. J Exp Med. 215:1169–1186. 2018.PubMed/NCBI View Article : Google Scholar
|
|
216
|
Broekaart DWM, Anink JJ, Baayen JC, Idema
S, de Vries HE, Aronica E, Gorter JA and van Vliet EA: Activation
of the innate immune system is evident throughout epileptogenesis
and is associated with blood-brain barrier dysfunction and seizure
progression. Epilepsia. 59:1931–1944. 2018.PubMed/NCBI View Article : Google Scholar
|
|
217
|
Zhao K, Bai X, Wang X, Cao Y, Zhang L, Li
W and Wang S: Insight on the hub gene associated signatures and
potential therapeutic agents in epilepsy and glioma. Brain Res
Bull. 199(110666)2023.PubMed/NCBI View Article : Google Scholar
|
|
218
|
McDonough SI, Boland LM, Mintz IM and Bean
BP: Interactions among toxins that inhibit N-type and P-type
calcium channels. J Gen Physiol. 119:313–328. 2002.PubMed/NCBI View Article : Google Scholar
|
|
219
|
Lewis RJ, Dutertre S, Vetter I and
Christie MJ: Conus venom peptide pharmacology. Pharmacol Rev.
64:259–298. 2012.PubMed/NCBI View Article : Google Scholar
|
|
220
|
Li L, Zhang C, Wang Z, Guo Y, Wang Y, Fan
X and Jiang T: Expression changes in ion channel and immunity genes
are associated with glioma-related epilepsy in patients with
diffuse gliomas. J Cancer Res Clin Oncol. 148:2793–2802.
2022.PubMed/NCBI View Article : Google Scholar
|
|
221
|
Jin Y, Zhao C, Chen L, Liu X, Pan S, Ju D,
Ma J, Li J and Wei B: Identification of novel gene and pathway
targets for human epilepsy treatment. Biol Res.
49(3)2016.PubMed/NCBI View Article : Google Scholar
|
|
222
|
Li S, Han J, Guo G, Sun Y, Zhang T, Zhao
M, Xu Y, Cui Y, Liu Y and Zhang J: Voltage-gated sodium channels β3
subunit promotes tumorigenesis in hepatocellular carcinoma by
facilitating p53 degradation. FEBS Lett. 594:497–508.
2020.PubMed/NCBI View Article : Google Scholar
|
|
223
|
Li S, Shao H and Chang L: The important
role of perituberal tissue in epileptic patients with tuberous
sclerosis complex by the transcriptome analysis. Biomed Res Int.
2020(4980609)2020.PubMed/NCBI View Article : Google Scholar
|
|
224
|
Vecht CJ, Kerkhof M and Duran-Pena A:
Seizure prognosis in brain tumors: New insights and evidence-based
management. Oncologist. 19:751–759. 2014.PubMed/NCBI View Article : Google Scholar
|
|
225
|
Wang R, Yang S, Wang M, Zhou Y, Li X, Chen
W, Liu W, Huang Y, Wu J, Cao J, et al: A sustainable approach to
universal metabolic cancer diagnosis. Nature Sustainability.
7:602–615. 2024.
|
|
226
|
Yuan Y, Zhang X, Wang Y, Li H, Qi Z, Du Z,
Chu Y-H, Feng D, Xie Q, Song J, et al: Multimodal data integration
using deep learning predicts overall survival of patients with
glioma. View. 5(20240001)2024.
|
